Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'positive symptoms' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 165 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Stieglitz, RD; Vauth, R
      Efficacy of cognitive-behavioral therapy in the treatment of persistent positive symptoms - Is there any progress?

      ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE
    2. Klemm, S; Gerhard, UJ; Blanz, B
      Risk for schizophrenia and imaging procedure in cerebral membrane metabolism

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    3. Oosthuizen, P; Emsley, RA
      First-episode psychosis: lessons from 15 years of research

      PRIMARY CARE PSYCHIATRY
    4. Moritz, S; Andresen, B; Jacobsen, D; Mersmann, K; Wilke, U; Lambert, M; Naber, D; Krausz, M
      Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics

      EUROPEAN PSYCHIATRY
    5. Cuesta, MJ; Peralta, V
      Integrating psychopathological dimensions in functional psychoses: a hierarchical approach

      SCHIZOPHRENIA RESEARCH
    6. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    7. Peralta, V; Cuesta, MJ
      How many and which are the psychopathological dimensions in schizophrenia?Issues influencing their ascertainment

      SCHIZOPHRENIA RESEARCH
    8. Gould, RA; Mueser, KT; Bolton, E; Mays, V; Goff, D
      Cognitive therapy for psychosis in schizophrenia: an effect size analysis

      SCHIZOPHRENIA RESEARCH
    9. Emsley, RA; Niehaus, DJH; Mbanga, NI; Oosthuizen, PP; Stein, DJ; Maritz, JS; Pimstone, SN; Hayden, MR; Laurent, C; Deleuze, JF; Mallet, J
      The factor structure for positive and negative symptoms in South African Xhosa patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    10. Johnson-Selfridge, M; Zalewski, C
      Moderator variables of executive functioning in schizophrenia: Meta-analytic findings

      SCHIZOPHRENIA BULLETIN
    11. Lecrubier, Y; Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lemperiere, T; Lisoprawski, A; Petitjean, F; Vanelle, JM
      Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia

      NEUROPSYCHOBIOLOGY
    12. Stirling, JD; Hellewell, JSE; Ndlovu, D
      Self-monitoring dysfunction and the positive symptoms of schizophrenia

      PSYCHOPATHOLOGY
    13. Lykouras, L; Oulis, P; Daskalopoulou, E; Psarros, K; Christodoulou, GN
      Clinical subtypes of schizophrenic disorders: A cluster analytic study

      PSYCHOPATHOLOGY
    14. Paez, F; Apiquian, R; Fresan, A; Puig, A; Orozco, B; De la Fuente, JR; Sidenberg, D; Nicolini, H
      Dermatoglyphic study of positive and negative symptoms in schizophrenia

      SALUD MENTAL
    15. Kasckow, JW; Twamley, E; Mulchahey, JJ; Carroll, B; Sabai, M; Strakowski, SM; Patterson, T; Jeste, DV
      Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients

      PSYCHIATRY RESEARCH
    16. Getz, GE; Fleck, DE; Strakowski, SM
      Frequency and severity of religious delusions in Christian patients with psychosis

      PSYCHIATRY RESEARCH
    17. Kotlicka-Antczak, M; Gmitrowicz, A; Sobow, TM; Rabe-Jablonska, J
      Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms

      JOURNAL OF PSYCHIATRIC RESEARCH
    18. Slaghuis, WL; Bishop, AM
      Luminance flicker sensitivity in positive- and negative-symptom schizophrenia

      EXPERIMENTAL BRAIN RESEARCH
    19. Lindamer, LA; Buse, DC; Lohr, JB; Jeste, DV
      Hormone replacement therapy in postmenopausal women with schizophrenia: Positive effect on negative symptoms?

      BIOLOGICAL PSYCHIATRY
    20. McGrath, J; Chapple, B; Wright, M
      Working memory in schizophrenia and mania: Correlation with symptoms during the acute and subacute phases

      ACTA PSYCHIATRICA SCANDINAVICA
    21. Hale, A; Azorin, JM; Kasper, S; Maier, W; Syvalahti, E; Van der Burght, M; Sloth-Nielsen, M; Wehnert, A
      Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    22. Dyck, DG; Short, RA; Hendryx, MS; Norell, D; Myers, M; Patterson, T; McDonell, MG; Voss, WD; Mcfarlane, WR
      Management of negative symptoms among patients with schizophrenia attending multiple-family groups

      PSYCHIATRIC SERVICES
    23. Banaschewski, T; Schulz, E; Martin, M; Remschmidt, H
      Cognitive functions and psychopathological symptoms in early-onset schizophrenia

      EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
    24. Ellenbroek, BA; Cools, AR
      Animal models for the negative symptoms of schizophrenia

      BEHAVIOURAL PHARMACOLOGY
    25. Verhoeff, NPLG; Meyer, JH; Kecojevic, A; Hussey, D; Lewis, R; Tauscher, J; Zipursky, RB; Kapur, S
      A voxel-by-voxel analysis of [F-18]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    26. Rossi, A; Pollice, R; Daneluzzo, E; Marinangeli, MG; Stratta, P
      Behavioral neurodevelopment abnormalities and schizophrenic disorder: a retrospective evaluation with the Childhood Behavior Checklist (CBCL)

      SCHIZOPHRENIA RESEARCH
    27. Mata, I; Sham, PC; Gilvarry, CM; Jones, PB; Lewis, SW; Murray, RM
      Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives

      SCHIZOPHRENIA RESEARCH
    28. Atre-Vaidya, N
      Significance of abnormal brain perfusion in catatonia: A case report

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    29. Silver, H; Barash, I; Aharon, N; Kaplan, A; Poyurovsky, M
      Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    30. Kerwin, R
      From pharmacological profiles to clinical outcomes

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    31. Azorin, JM
      Acute phase of schizophrenia: impact of atypical antipsychotics

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    32. Peuskens, J
      Switching approach in the management of schizophrenia patients

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    33. Lecrubier, Y
      Is amisulpride an 'atypical' atypical antipsychotic agent?

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    34. Marengo, J; Harrow, M; Herbener, ES; Sands, J
      A prospective longitudinal 10-year study of schizophrenia's three major factors and depression

      PSYCHIATRY RESEARCH
    35. Dawson, ME; Schell, AM; Hazlett, EA; Nuechterlein, KH; Filion, DL
      On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia

      PSYCHIATRY RESEARCH
    36. Kontaxakis, VP; Havaki-Kontaxaki, BJ; Margariti, MM; Stamouli, SS; Kollias, CT; Angelopoulos, EK; Christodoulou, GN
      The Greek version of the Calgary depression scale for schizophrenia

      PSYCHIATRY RESEARCH
    37. Lancon, C; Auquier, P; Reine, G; Bernard, D; Toumi, M
      Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS)

      JOURNAL OF AFFECTIVE DISORDERS
    38. Sabri, O; Hellwig, D; Schreckenberger, M; Schneider, R; Kaiser, HJ; Wagenknecht, G; Mull, M; Buell, U
      Influence of diabetes mellitus on regional cerebral glucose metabolism andregional cerebral blood flow

      NUCLEAR MEDICINE COMMUNICATIONS
    39. Riehemann, S; Volz, HP; Smesny, S; Hubner, G; Wenda, B; Rossger, G; Sauer, H
      (31)Phosphorus magnetic resonance spectroscopy in schizophrenia research. On the pathophysiology of the cerebral high energy phosphate and membrane phospholipid metabolism

      NERVENARZT
    40. Muller, MJ; Rossbach, W; Davids, E; Wetzel, H; Benkert, O
      Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS)

      NERVENARZT
    41. Cooper, SJ; Tweed, J; Raniwalla, J; Butler, A; Welch, C
      A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia

      ACTA PSYCHIATRICA SCANDINAVICA
    42. Bottlender, R; Strauss, A; Moller, HJ
      Prevalence and background factors of depression in first admitted schizophrenic patients

      ACTA PSYCHIATRICA SCANDINAVICA
    43. Chanpattana, W; Chakrabhand, S; Sackeim, HA; Kitaroonchai, W; Kongsakon, R; Techakasem, P; Buppanharun, W; Tuntirungsee, Y; Kirdcharoen, N
      Continuation ECT in treatment-resistant schizophrenia: A controlled study

      JOURNAL OF ECT
    44. Chanpattana, W; Chakrabhand, MLS; Kongsakon, R; Techakasem, P; Buppanharun, W
      Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia

      JOURNAL OF ECT
    45. Read, J; Argyle, N
      Hallucinations delusions, and thought disorder among adult psychiatric inpatients with a history of child abuse

      PSYCHIATRIC SERVICES
    46. Verhoeff, NPLG; Soares, JC; D'Souza, CD; Gil, R; Degen, K; Abi-Dargham, A; Zoghbi, SS; Fujita, M; Rajeevan, N; Seibyl, JP; Krystal, JH; van Dyck, CH; Charney, DS; Innis, RB
      [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    47. Erkwoh, R; Sabri, O; Willmes, K; Steinmeyer, EM; Bull, U; Sass, H
      Active and remitted schizophrenia: psychopathological and regional cerebral blood flow findings

      PSYCHIATRY RESEARCH-NEUROIMAGING
    48. Bender, S; Schall, U; Wolstein, J; Grzella, I; Zerbin, D; Oades, RD
      A topographic event-related potential follow-up study on 'prepulse inhibition' in first and second episode patients with schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    49. Chouinard, G; Miller, R
      A Rating Scale for Psychotic Symptoms (RSPS) Part I: theoretical principles and subscale 1: perception symptoms (illusions and hallucinations)

      SCHIZOPHRENIA RESEARCH
    50. Neumann, CS; Walker, EF
      Motor dysfunction in schizotypal personality disorder

      SCHIZOPHRENIA RESEARCH
    51. Peralta, V; Cuesta, MJ
      Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders

      SCHIZOPHRENIA RESEARCH
    52. Tandon, R; Taylor, SF; DeQuardo, JR; Eiser, A; Jibson, MD; Goldman, M
      The cholinergic system in schizophrenia reconsidered: Anticholinergic modulation of sleep and symptom profiles

      NEUROPSYCHOPHARMACOLOGY
    53. Fukuzako, H; Fukuzako, T; Kodama, S; Hashiguchi, T; Takigawa, M; Fujimoto, T
      Haloperidol improves membrane phospholipid abnormalities in temporal lobesof schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    54. Erkwoh, R; Sabri, O; Willmes, K; Steinmeyer, EM; Bull, U; Sass, H
      Aspects of connectivity in schizophrenia: Introduction

      FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
    55. Schreckenberger, M; Gouzoulis-Mayfrank, E; Sabri, O; Arning, C; Zimny, M; Zeggel, T; Wagenknecht, G; Kaiser, HJ; Sass, H; Buell, U
      "Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology - An 18-FDG PET Study

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    56. Bersani, G; Garavini, A; Taddei, I; Tanfani, G; Pancheri, P
      Choroid plexus calcification as a possible clue of serotonin implication in schizophrenia

      NEUROSCIENCE LETTERS
    57. Mauri, MC; Bitetto, A; Fabiano, L; Laini, V; Steinhilber, C; Fornier, M; Rafique, F
      Depressive symptoms and schizophrenic relapses: The effect of four neuroleptic drugs

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    58. Lancon, C; Auquier, P; Reine, G; Toumi, M; Addington, D
      Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale

      PSYCHIATRY RESEARCH
    59. Bow-Thomas, CC; Velligan, DI; Miller, AL; Olsen, J
      Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization

      PSYCHIATRY RESEARCH
    60. Dyck, DG; Short, R; Vitaliano, PP
      Predictors of burden and infectious illness in schizophrenia caregivers

      PSYCHOSOMATIC MEDICINE
    61. Mojtabai, R
      Duration of illness and structure of symptoms in schizophrenia

      PSYCHOLOGICAL MEDICINE
    62. Loffler, W; Hafner, H
      Replication of the 3-factor model by Liddle to a population-related first-episode sample of schizophrenic patients

      NERVENARZT
    63. Sakurai, M; Kanazawa, I
      Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    64. Sigmund, D; Mundt, C
      The cycloid type and its differentiation from core schizophrenia: A phenomenological approach

      COMPREHENSIVE PSYCHIATRY
    65. Park, S; Puschel, J; Sauter, BH; Rentsch, M; Hell, D
      Spatial working memory deficits and clinical symptoms in schizophrenia: A 4-month follow-up study

      BIOLOGICAL PSYCHIATRY
    66. Frodl-Bauch, T; Gallinat, J; Meisenzahl, EM; Moller, HJ; Hegerl, U
      P300 subcomponents reflect different aspects of psychopathology in schizophrenia

      BIOLOGICAL PSYCHIATRY
    67. HARRISON CA; DADDS MR; SMITH G
      FAMILY CAREGIVERS CRITICISM OF PATIENTS WITH SCHIZOPHRENIA

      Psychiatric services
    68. KITAMURA T; OKAZAKI Y; FUJINAWA A; TAKAGANAGI I; KASAHARA Y
      DIMENSIONS OF SCHIZOPHRENIC POSITIVE SYMPTOMS - AN EXPLORATORY FACTOR-ANALYSIS INVESTIGATION

      European archives of psychiatry and clinical neuroscience
    69. CUESTA MJ; PERALTA V; ZARZUELA A
      ILLNESS DURATION AND NEUROPSYCHOLOGICAL IMPAIRMENTS IN SCHIZOPHRENIA

      Schizophrenia research
    70. MULLER MJ; ROSSBACH W; DANNIGKEIT P; MULLERSIECHENEDER F; SZEGEDI A; WETZEL H
      EVALUATION OF STANDARDIZED RATER TRAINING FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)

      Schizophrenia research
    71. SMITH DA; MAR CM; TUROFF BK
      THE STRUCTURE OF SCHIZOPHRENIC SYMPTOMS - A METAANALYTIC CONFIRMATORYFACTOR-ANALYSIS

      Schizophrenia research
    72. SAMSDODD F
      EFFECTS OF CONTINUOUS D-AMPHETAMINE AND PHENCYCLIDINE ADMINISTRATION ON SOCIAL-BEHAVIOR, STEREOTYPED BEHAVIOR, AND LOCOMOTOR-ACTIVITY IN RATS

      Neuropsychopharmacology
    73. SAMSDODD F
      A TEST OF THE PREDICTIVE-VALIDITY OF ANIMAL-MODELS OF SCHIZOPHRENIA BASED ON PHENCYCLIDINE AND D-AMPHETAMINE

      Neuropsychopharmacology
    74. GRAY JA
      INTEGRATING SCHIZOPHRENIA

      Schizophrenia bulletin
    75. ODONNELL P; GRACE AA
      DYSFUNCTIONS IN MULTIPLE INTERRELATED SYSTEMS AS THE NEUROBIOLOGICAL BASES OF SCHIZOPHRENIC SYMPTOM CLUSTERS

      Schizophrenia bulletin
    76. Schreckenberger, C; Gouzoulis-Mayfrank, E; Sabri, O; Arning, C; Schulz, G; Tuttass, T; Wagenknecht, G; Kaiser, HJ; Sass, H; Buell, U
      Cerebral interregional correlations of associative language processing: a positron emission tomography activation study using fluorine-18 fluorodeoxyglucose

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    77. WOOD A
      CLINICAL-EXPERIENCE WITH OLANZAPINE, A NEW ATYPICAL ANTIPSYCHOTIC

      International clinical psychopharmacology
    78. CHOU JCY; DOUYON R; CZOBOR P; VOLAVKA J; COOPER TB
      CHANGE IN PLASMA PROLACTIN AND CLINICAL-RESPONSE TO HALOPERIDOL IN SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER

      Psychiatry research
    79. MAHURIN RK; VELLIGAN DI; MILLER AL
      EXECUTIVE-FRONTAL LOBE COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA - A SYMPTOM SUBTYPE ANALYSIS

      Psychiatry research
    80. LIN ASK; CHEN CH; HWU HG; LIN HN; CHEN JA
      PSYCHOPATHOLOGICAL DIMENSIONS IN SCHIZOPHRENIA - A CORRELATIONAL APPROACH TO ITEMS OF THE SANS AND SAPS

      Psychiatry research
    81. Sams-Dodd, F
      Effects of diazepam, citalopram, methadone and naloxone on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    82. NISENSON LG; BERENBAUM H
      INTERPERSONAL INTERACTIONS IN INDIVIDUALS WITH SCHIZOPHRENIA - INDIVIDUAL-DIFFERENCES AMONG PATIENTS AND THEIR PARTNERS

      Psychiatry
    83. TAM WCC; SEWELL KW; DENG HC
      INFORMATION-PROCESSING IN SCHIZOPHRENIA AND BIPOLAR DISORDER - A DISCRIMINANT-ANALYSIS

      The Journal of nervous and mental disease
    84. ZORRILLA EP; CANNON TD; KESSLER J; GUR RE
      LEUKOCYTE DIFFERENTIALS PREDICT SHORT-TERM CLINICAL OUTCOME FOLLOWINGANTIPSYCHOTIC TREATMENT IN SCHIZOPHRENIA

      Biological psychiatry
    85. TROISI A; SPALLETTA G; PASINI A
      NONVERBAL BEHAVIOR DEFICITS IN SCHIZOPHRENIA - AN ETHOLOGICAL STUDY OF DRUG-FREE PATIENTS

      Acta psychiatrica Scandinavica
    86. ADDINGTON J; ADDINGTON D; GASBARRE L
      DISTRACTIBILITY AND SYMPTOMS IN SCHIZOPHRENIA

      Journal of psychiatry & neuroscience
    87. CASCON II; MEDINA PG
      PSYCHOMETRIC CHARACTERISTICS OF THE POSIT IVE AND NEGATIVE SYMPTOMS ANDREASEN SCALES OF SCHYZOPHRENY

      Psicologia conductual
    88. AMMINGER GP; RESCH F; MUTSCHLECHNER R; FRIEDRICH MH; ERNST E
      PREMORBID ADJUSTMENT AND REMISSION OF POSITIVE SYMPTOMS IN FIRST-EPISODE PSYCHOSIS

      European child & adolescent psychiatry
    89. SAMSDODD F
      EFFECT OF NOVEL ANTIPSYCHOTIC-DRUGS ON PHENCYCLIDINE-INDUCED STEREOTYPED BEHAVIOR AND SOCIAL-ISOLATION IN THE RAT SOCIAL-INTERACTION TEST

      Behavioural pharmacology
    90. ROITMAN SEL; KEEFE RSE; HARVEY PD; SIEVER LJ; MOHS RC
      ATTENTIONAL AND EYE TRACKING DEFICITS CORRELATE WITH NEGATIVE SYMPTOMS IN SCHIZOPHRENIA

      Schizophrenia research
    91. PROVENCHER HL; MUESER KT
      POSITIVE AND NEGATIVE SYMPTOM BEHAVIORS AND CAREGIVER BURDEN IN THE RELATIVES OF PERSONS WITH SCHIZOPHRENIA

      Schizophrenia research
    92. NAKAYA M; OHMORI K; KOMAHASHI T; SUWA H
      DEPRESSIVE SYMPTOMS IN ACUTE SCHIZOPHRENIC INPATIENTS

      Schizophrenia research
    93. BERMAN I; VIEGNER B; MERSON A; ALLAN E; PAPPAS D; GREEN AI
      DIFFERENTIAL RELATIONSHIPS BETWEEN POSITIVE AND NEGATIVE SYMPTOMS ANDNEUROPSYCHOLOGICAL DEFICITS IN SCHIZOPHRENIA

      Schizophrenia research
    94. SCHULTZ SK; MILLER DD; OLIVER SE; ARNDT S; FLAUM M; ANDREASEN NC
      THE LIFE-COURSE OF SCHIZOPHRENIA - AGE AND SYMPTOM DIMENSIONS

      Schizophrenia research
    95. HIRSCHOWITZ J; HITZEMANN R; PISCANI K; BURR G; FRECSKA E; CULLITON D; MANN M; CURTIS C
      THE DOSE REDUCTION IN SCHIZOPHRENIA (DORIS) STUDY - A FINAL REPORT

      Schizophrenia research
    96. GOODMAN LA; ROSENBERG SD; MUESER KT; DRAKE RE
      PHYSICAL AND SEXUAL ASSAULT HISTORY IN WOMEN WITH SERIOUS MENTAL-ILLNESS - PREVALENCE, CORRELATES, TREATMENT, AND FUTURE-RESEARCH DIRECTIONS

      Schizophrenia bulletin
    97. PIVAC N; MUCKSELER D; JAKOVLJEVIC M
      PLATELET 5-HT LEVELS AND HYPOTHALAMIC-PITUITARY-ADRENAL AXIS ACTIVITYIN SCHIZOPHRENIC-PATIENTS WITH POSITIVE AND NEGATIVE SYMPTOMS

      Neuropsychobiology
    98. EARNST KS; KRING AM
      CONSTRUCT-VALIDITY OF NEGATIVE SYMPTOMS - AN EMPIRICAL AND CONCEPTUALREVIEW

      Clinical psychology review
    99. WILLNER P
      THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - CURRENT STATUS, FUTURE-PROSPECTS

      International clinical psychopharmacology
    100. ANDREASEN NC
      IMPROVEMENT OF NEGATIVE SYMPTOMS - CONCEPTS, DEFINITION AND ASSESSMENT

      International clinical psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:19:24